{"id":"NCT00375713","sponsor":"UCB Pharma","briefTitle":"Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema","officialTitle":"A Multi-centre, Double-blind, Double-dummy, Randomized, Active-controlled Phase III Study to Evaluate the Efficacy and Safety of Xyzal® 5mg od vs Zyrtec® 10mg od in Subjects Aged 15 Years and Above With Dermatitis and Eczema","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-10","primaryCompletion":"2006-05","completion":"2006-05","firstPosted":"2006-09-13","resultsPosted":"2009-10-14","lastUpdate":"2011-08-31"},"enrollment":466,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dermatitis","Eczema"],"interventions":[{"type":"DRUG","name":"Levocetirizine","otherNames":["Xyzal®"]},{"type":"DRUG","name":"Cetirizine","otherNames":["Zyrtec®"]},{"type":"DRUG","name":"Placebo-Levocetirizine","otherNames":[]},{"type":"DRUG","name":"Placebo-Cetirizine","otherNames":[]},{"type":"DRUG","name":"Standard topical steroid (1% hydrocortisone) ointment","otherNames":[]}],"arms":[{"label":"Levocetirizine","type":"EXPERIMENTAL"},{"label":"Cetirizine","type":"ACTIVE_COMPARATOR"}],"summary":"Korean double-blind non-inferiority study to asses the efficacy (as measured by the responder rate of pruritus severity score by the patient at visit 4 or end-of-treatment visit over the 2 weeks treatment period) and safety of Xyzal® to Zyrtec® in subjects suffering from dermatitis and eczema with pruritus symptoms","primaryOutcome":{"measure":"Responder Status According to Pruritus Severity Score (Response = Mild or None in Pruritus Severity Score).","timeFrame":"Day 7 and 14","effectByArm":[{"arm":"Levocetirizine","deltaMin":131,"sd":null},{"arm":"Cetirizine","deltaMin":134,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":3,"countries":["South Korea"]},"refs":{"pmids":[],"seeAlso":["http://www.fda.gov/Safety/MedWatch/SafetyInformation/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":209},"commonTop":["Rhinitis"]}}